Pharmaceutical

Sanofi signs radioligand therapy licensing deal for rare cancers

Sanofi has signed a licensing agreement with RadioMedix and Orano Med to advance a radioligand therapy, AlphaMedix.

Sep 14, 2024 - 04:00
Sanofi signs radioligand therapy licensing deal for rare cancers
Sanofi has signed a licensing agreement with RadioMedix and Orano Med to advance a radioligand therapy, AlphaMedix.
Read the original article

Tags:

Previous Article

Into the unknown: How quickly can vaccines be developed for Disease X

Next Article

Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How rising stars in science and medicine think about mentorship and bouncing back from rejection

How rising stars in science and medicine think about me...

Oct 18, 2023

Opinion: Sickle cell cures are coming. African children can’t be left behind

Opinion: Sickle cell cures are coming. African children...

Jul 12, 2023

FibroGen’s pamrevlumab disappointing results marks second failure in a row

FibroGen’s pamrevlumab disappointing results marks seco...

Aug 30, 2023